Relay Therapeutics, Inc.

RLAY · Healthcare · Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company

Relay Therapeutics, Inc. (RLAY), in the Healthcare sector, has 22 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 22 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 9. The most active filer was Thomas Catinazzo with 10 filings.

Add to watchlist

Filings, ttm

0 buys · 22 sells · 1 late

Traders, ttm

5 insiders

Volume, ttmiDollar value disclosed in the window

$128.6M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 8

Filed Sep 9

ADViAverage daily dollar volume

$74.0M

market data

Share price · 12M

$19.01 (+318.7%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $133.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Thomas Catinazzo Chief Financial Officer 10 filings SP

Sanjiv Patel President and CEO 10 filings DB

Donald A Bergstrom President, R&D 6 filings PR

Peter Rahmer See remarks 4 filings BA

Brian Adams Chief Legal Officer 1 filing SL SVF Pauling (Cayman) Ltd 10% owner 1 filing

Recent filings

Donald A BergstromSALE President, R&D $162K
8,530 sh × $18.97
Exec Sep 8
Filed Sep 9 · 4:17 PM ET Thomas CatinazzoSALE Chief Financial Officer $336K
17,717 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:15 PM ET Sanjiv PatelSALE President and CEO $913K
48,199 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:12 PM ET SVF Pauling (Cayman) LtdSALE 10% owner $116.4M
6,000,000 sh × $19.40
Exec Aug 25
Filed Aug 28 · 9:01 AM ET † Sanjiv PatelSALE President and CEO $980K
48,199 sh × $20.33
Exec Aug 17
Filed Aug 18 · 4:17 PM ET Thomas CatinazzoSALE Chief Financial Officer $350K
17,717 sh × $19.74
Exec Aug 14
Filed Aug 18 · 4:16 PM ET Donald A BergstromSALE President, R&D $162K
8,660 sh × $18.71
Exec Jul 6
Filed Jul 8 · 5:11 PM ET Sanjiv PatelSALE President and CEO $944K
48,199 sh × $19.58
Exec Jul 7
Filed Jul 8 · 5:08 PM ET Thomas CatinazzoSALE Chief Financial Officer $331K
17,717 sh × $18.69
Exec Jul 6
Filed Jul 8 · 5:07 PM ET Peter RahmerSALE See remarks $954K
50,000 sh × $19.09
Exec Jun 30
Filed Jul 2 · 4:12 PM ET Donald A BergstromSALE President, R&D $1.6M
93,456 sh × $16.94
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Thomas CatinazzoSALE Chief Financial Officer $3.2M
187,163 sh across 4 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Thomas CatinazzoSALE Chief Financial Officer $228K
17,717 sh × $12.86
Exec May 14
Filed May 14 · 5:30 PM ET Thomas CatinazzoSALE Chief Financial Officer $230K
17,717 sh × $13.01
Exec Apr 7
Filed Apr 9 · 5:30 PM ET Thomas CatinazzoSALE Chief Financial Officer $178K
17,717 sh × $10.06
Exec Mar 9
Filed Mar 11 · 5:30 PM ET Thomas CatinazzoSALE Chief Financial Officer $105K
13,820 sh × $7.62
Exec Jan 27
Filed Jan 29 · 5:30 PM ET Donald A BergstromSALE President, R&D $144K
18,895 sh × $7.62
Exec Jan 27
Filed Jan 29 · 5:30 PM ET Sanjiv PatelSALE President and CEO $338K
43,168 sh × $7.82
Exec Jan 6
Filed Jan 7 · 5:30 PM ET Sanjiv PatelSALE President and CEO $435K
62,073 sh × $7.00
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET Donald A BergstromSALE President, R&D $225K
30,897 sh × $7.29
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET Thomas CatinazzoSALE Chief Financial Officer $158K
21,664 sh × $7.29
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET Peter RahmerSALE See remarks $300K
40,529 sh across 2 lots
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET Sanjiv PatelSALE President and CEO $153K
42,740 sh × $3.57
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET Sanjiv PatelSALE President and CEO $127K
42,769 sh × $2.97
Exec Apr 23 2025
Filed Apr 24 2025 · 5:30 PM ET Sanjiv PatelSALE President and CEO $818K
215,506 sh across 2 lots
Exec Feb 11 2025
Filed Feb 13 2025 · 5:30 PM ET